Delamanid
Deltyba (delamanid) is a small molecule pharmaceutical. Delamanid was first approved as Deltyba on 2014-04-27. It has been approved in Europe to treat multidrug-resistant tuberculosis.
Trade Name | Deltyba |
---|---|
Common Name | Delamanid |
Indication | multidrug-resistant tuberculosis |
Drug Class | Mycolic acid inhibitors |